Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia
Fuyin Yang,1–4 Lan Chen,5 Xinyu Fang,6 Ke Zheng,1 Cheng Zhu,1 Chaoqun Xu,1 Chen Zhang,6 Wei Tang11Wenzhou Kangning Hospital, School of Mental Health, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China; 2Faculty of Arts and Science, New York University Shanghai, Shanghai, China; 3S...
Enregistré dans:
| Auteurs principaux: | Yang F, Chen L, Fang X, Zheng K, Zhu C, Xu C, Zhang C, Tang W |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2018
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/37692098c58745cb846f45277ce9b339 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The effectiveness and safety of amisulpride in Chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the ESCAPE study
par: Liang Y, et autres
Publié: (2017) -
Reversal of olanzapine-induced weight gain in a patient with schizophrenia by switching to asenapine: a case report
par: Okazaki K, et autres
Publié: (2017) -
Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia
par: Katagiri H, et autres
Publié: (2018) -
Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
par: Zhi P, et autres
Publié: (2018) -
Safety and effectiveness of rapid-acting intramuscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study
par: Katagiri H, et autres
Publié: (2018)